Caporali and co-workers performed an exhaustive study on the role of AAAs in optic neuropathy where their studies showed using both yeast and patient fibroblast that AFG3L2 mutations indirectly affect OPA1 processing, resulting in mitochondrial fragmentation not seen in SCA28 patients. This evidence concerns the gene AFG3L2 and optic nerve disorder.